Related references
Note: Only part of the references are listed.Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Frequent Attenuation of the WWOX Tumor Suppressor in Osteosarcoma Is Associated with Increased Tumorigenicity and Aberrant RUNX2 Expression
Kyle C. Kurek et al.
CANCER RESEARCH (2010)
WWOX gene and gene product: tumor suppression through specific protein interactions
Zaidoun Salah et al.
FUTURE ONCOLOGY (2010)
Fragile Histidine Triad Protein, WW Domain-containing Oxidoreductase Protein Wwox, and Activator Protein 2γ Expression Levels Correlate With Basal Phenotype in Breast Cancer
Gulnur Guler et al.
CANCER (2009)
WWOX: Its Genomics, Partners, and Functions
Sara Del Mare et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Breast cancer: origins and evolution
Kornelia Polyak
JOURNAL OF CLINICAL INVESTIGATION (2007)
Association of Wwox with ErbB4 in breast cancer
Rami I. Aqeilian et al.
CANCER RESEARCH (2007)
Comparison of gene expression data from human and mouse breast cancers: Identification of a conserved breast tumor gene set
Andreas Klein et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Inactivation of the WWOX gene accelerates forestomach tumor progression in vivo
Rami I. Aqeilan et al.
CANCER RESEARCH (2007)
Targeted deletion of Wwox reveals a tumor suppressor function
Rami I. Aqeilan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Inhibition of breast cancer cell growth in vitro and in vivo: Effect of restoration of Wwox expression
Dimitrios Iliopoulos et al.
CLINICAL CANCER RESEARCH (2007)
WW domain binding protein-2, an E6-associated protein interacting protein, acts as a coactivator of estrogen and progesterone receptors
Sarath C. Dhananjayan et al.
MOLECULAR ENDOCRINOLOGY (2006)
Concordant loss of fragile gene expression early in breast cancer development
G Guler et al.
PATHOLOGY INTERNATIONAL (2005)
Decreased expression of E6-associated protein in breast and prostate carcinomas
XH Gao et al.
ENDOCRINOLOGY (2005)
Frequent loss of WWOX expression in breast cancer: correlation with estrogen receptor status
M Nunez et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
From mice to humans:: Identification of commonly deregulated genes in mammary cancer via comparative SAGE studies
YH Hu et al.
CANCER RESEARCH (2004)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Common chromosomal fragile site FRA16D sequence:: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells
K Ried et al.
HUMAN MOLECULAR GENETICS (2000)
Estimation of tamoxifen's efficacy for preventing the formation and growth of breast tumors
MD Radmacher et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
